Martin Norin
Operationeel Directeur bij KANCERA AB
Actieve functies van Martin Norin
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| KANCERA AB | Operationeel Directeur | - | - |
Loopbaan van Martin Norin
Eerdere bekende functies van Martin Norin
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Pharmacia AB | Corporate Officer/Principal | - | - |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | - | - |
iNovacia AB
 iNovacia AB Miscellaneous Commercial ServicesCommercial Services Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million. | Directeur/Bestuurslid | 10-05-2011 | - |
| Hoofd Techniek/Wetenschap/O&O | 10-05-2011 | - | |
| Oprichter | 10-05-2011 | 05-06-2012 |
Opleiding van Martin Norin
| Royal Institute of Technology | Doctorate Degree |
Statistieken
Internationaal
| Zweden | 6 |
Operationeel
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
| Director/Board Member | 1 |
Sectoraal
| Health Technology | 3 |
| Commercial Services | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| KANCERA AB | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
iNovacia AB
iNovacia AB Miscellaneous Commercial ServicesCommercial Services Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million. | Commercial Services |
| Pharmacia AB | Health Technology |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
- Beurs
- Insiders
- Martin Norin
- Ervaring
